For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

In about 5–10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DUPAGE COUNTY, Ill. (WGN) — It’s a quiet day ...

Researchers at Baylor Scott & White Research Institute identified a new genetic biomarker for colon cancer that may lead to development of more targeted treatment of the disease. The study, which ...

Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in colon cancer risk. Aging, more ...

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments. Genetic testing is a laboratory method ...

FDA has announced it has approved the first genetic test that can help some colorectal cancer patients and their doctors determine if the drug Erbitux (cetuximab) would be an effective treatment based ...

At one time, colorectal disease was considered to be a disorder of older adults. But the demographics of patients have changed significantly in recent years, and colorectal cancer rates are rising ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...